An update on community-associated MRSA virulence

被引:68
|
作者
Kobayashi, Scott D. [1 ]
DeLeo, Frank R. [1 ]
机构
[1] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA
基金
美国国家卫生研究院;
关键词
RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; CASSETTE CHROMOSOME MEC; ALPHA-TOXIN; NECROTIZING PNEUMONIA; HUMAN NEUTROPHILS; SKIN INFECTIONS; IMMUNE EVASION; EMERGENCE; CLONE;
D O I
10.1016/j.coph.2009.07.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Staphylococcus aureus is a major health problem worldwide and the leading cause of bacterial infections in the United States. Historically, the success of S. aureus as a human pathogen has been facilitated by a strong propensity to develop antibiotic resistance and multidrug resistant strains are endemic in hospitals. However, one of the most striking developments in recent bacterial infectious disease history was the rapid emergence of community-associated methicillin-resistant S. aureus (CA-MRSA). First reported in the 1990s, CA-MRSA has since emerged worldwide and is epidemic in the United States. The pathogen is characterized by its ability to spread rapidly and cause infections in otherwise healthy individuals. This review focuses on current progress toward understanding the enhanced virulence properties of CA-MRSA, with an emphasis on Panton-Valentine leukocidin, alpha-hemolysin, and the recently discovered a-type phenol-soluble modulins.
引用
收藏
页码:545 / 551
页数:7
相关论文
共 50 条
  • [21] Glycopeptide and daptomycin resistance in community-associated MRSA in the UK
    A. Kirby
    C. Edwards
    C. M. Broughton
    N. J. Williams
    Infection, 2011, 39 : 277 - 279
  • [22] Glycopeptide and daptomycin resistance in community-associated MRSA in the UK
    Kirby, A.
    Edwards, C.
    Broughton, C. M.
    Williams, N. J.
    INFECTION, 2011, 39 (03) : 277 - 279
  • [23] Illicit drug use and community-associated MRSA bacteremia
    Kreisel, K.
    Johnson, J.
    Shardell, M.
    Perencevich, E.
    Stine, O.
    Roghmann, M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (11) : S74 - S74
  • [24] Diagnosis and management of community-associated MRSA infections in children
    Long, Caroline B.
    Madan, Rebecca P.
    Herold, Betsy C.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (02) : 183 - 195
  • [25] Community-Associated MRSA Coming to a Patient Near You?
    Mendyk, Michelle K.
    NURSE PRACTITIONER, 2008, 33 (03): : 26 - 32
  • [26] Chorioamnionitis and Neonatal Sepsis from Community-associated MRSA
    Pimentel, Jason D.
    Meier, Frederick A.
    Samuel, Linoj P.
    EMERGING INFECTIOUS DISEASES, 2009, 15 (12) : 2069 - 2071
  • [27] Intermediate vancomycin susceptibility in a community-associated MRSA clone
    Graber, Christopher J.
    Wong, Margaret K.
    Carleton, Heather A.
    Perdreau-Remington, Francoise
    Haller, Barbara L.
    Chambers, Henry F.
    EMERGING INFECTIOUS DISEASES, 2007, 13 (03) : 491 - 493
  • [28] Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
    Rossi, Flavia
    Diaz, Lorena
    Wollam, Aye
    Panesso, Diana
    Zhou, Yanjiao
    Rincon, Sandra
    Narechania, Apurva
    Xing, Galen
    Di Gioia, Thais S. R.
    Doi, Andre
    Tran, Truc T.
    Reyes, Jinnethe
    Munita, Jose M.
    Carvajal, Lina P.
    Hernandez-Roldan, Alejandra
    Brandao, Denise
    van der Heijden, Inneke Marie
    Murray, Barbara E.
    Planet, Paul J.
    Weinstock, George M.
    Arias, Cesar A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16): : 1524 - 1531
  • [29] Community-associated MRSA: What makes them special?
    Otto, Michael
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 303 (6-7) : 324 - 330
  • [30] Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis
    Millar, B. Cherie
    Prendergast, Bernard D.
    Moore, John E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (01) : 1 - 7